CURATIVE BIOSCIENCES, INC.
MIAMI, FLORIDA

CURATIVE BIOSCIENCES, INC., MIAMI

Our Mission Curative Biosciences’ mission is to help people live healthier, happier lives. Naturally. We translate advances in science and technology into safe and effective health products that make you feel your best. Staying true to our vision and values will guide us toward continued growth and success for years to come. As you read more about our vision and values, you will learn about who we are, where we’re headed and how every Curative Biosciences team member can help us get there. Curative Biosciences is creating a new category in the health industry by translating advances in science and technology into effective, scientifically sound health products available to people in their everyday lives. We are developing a portfolio of product with compelling compounds found in nature that offer an opportunity for our customers to proactively support their health. We offer a portfolio of hemp-derived CBD products including CBD oils, CBD softgels and CBD topicals. Our marketing aspirations are global. Besides the United States, our goal is to establish a formidable reputation as a reliable CBD oil supplements provider in more than 40 countries around the world. In Research and Development, our team is working in areas crucial to our existing business and future operations. Over 20 CBD oil products skus in different phases of development are an indication of the of our commitment to our research effort. For Curative Biosciences, CBD research is an essential part of what it means to be a learning organization and answering questions of efficacy and affordability. Curative Biosciences CBD research drives the generation of knowledge to inform clinical decision-making and ensure innovation, quality, safety, and value in CBD oil product development. Curative Biosciences’ research network addresses critical issues like diabetes, cancer, rheumatoid arthritis, brain and nerve damage due to stroke, alcoholism, nausea, and Huntington’s disease by leveraging our research expertise and data sources. Curative Biosciences, Inc. We offer a portfolio of hemp-derived CBD products including CBD oils, CBD softgels and CBD topicals. Our marketing aspirations are global. Besides the United States, our goal is to establish a formidable reputation as the premier CBD oil supplements provider in more than 40 countries around the world. In Research and Development, our team is working in areas crucial to our existing business and future operations. Over 20 CBD oil products skus in different phases of development are an indication of the of our commitment to our research effort. At Curative Biosciences, CBD research is an essential part of what it means to be a learning and answering questions of efficacy and affordability. Curative Biosciences CBD research drives the generation of knowledge to inform clinical decision-making and ensure innovation, quality, safety, and value in CBD oil product development. Curative Biosciences’ research network addresses critical issues like diabetes, cancer, rheumatoid arthritis, brain and nerve damage due to stroke, alcoholism, nausea, and Huntington’s disease by leveraging our research expertise and data sources. Curative Biosciences, Inc.

KEY FACTS ABOUT CURATIVE BIOSCIENCES, INC.

Company name
CURATIVE BIOSCIENCES, INC.
Status
Inactive
Filed Number
F18000000574
FEI Number
823977585
Date of Incorporation
February 2, 2018
Home State
NV
Company Type
Foreign for Profit

CONTACTS

Website
http://curativebiosciences.com
Phones
(949) 287-3164
(801) 272-9294
(801) 277-3147

CURATIVE BIOSCIENCES, INC. NEAR ME

Principal Address
801 BRICKELL AVE,
MIAMI,
FL,
33131,
US

See Also

Officers and Directors

The CURATIVE BIOSCIENCES, INC. managed by the two persons from MIAMI on following positions: CVCD, Treasurer

Katherine West

Position
CVCD Active
From
MIAMI, 33131

William Lindberg

Position
Treasurer Active
From
MIAMI, 33131





Registered Agent is Katherine West

From
MIAMI, 33131

Events

September 25, 2020
REVOKED FOR ANNUAL REPORT
October 15, 2019
REINSTATEMENT
September 27, 2019
REVOKED FOR ANNUAL REPORT

Annual Reports

2019
October 15, 2019